Rich Brennan
April 4, 2023
Accelerated Approval Pathway for ALS Drug, Copay Accumulators Under Review
Rich Brennan, Vice President of Federal Affairs for the ALS Association, explains the approval pathway for Tofersen, a new ALS drug, and what that means for patients; Peter Pitts, President and co-founder of the Center for M…
None